Sveriges Riksbank
CONDITIONS FOR RIKSBANK AUCTIONS GOVERNMENT BONDS
CONDITIONS FOR RIKSBANK AUCTIONS GOVERNMENT BONDS
| Bid procedure, 2025-10-17 | |
| Bonds | SWEDISH GOVERNMENT: 1061. SE0011281922. 2029-11-12 SWEDISH GOVERNMENT: 1053, SE0002829192, 2039-03-30 |
| Bid date | 2025-10-17 |
| Bid times | 09.00-10.00 (CET/CEST) on the Bid date |
| Offered volume (corresponding nominal amount) | 1061: 2000 million SEK +/-2000 million SEK 1053: 700 million SEK +/-700 million SEK |
| Highest permitted bid volume (corresponding nominal amount) | 1061: 2000 million SEK per bid 1053: 700 million SEK per bid |
| Lowest permitted bid volume (corresponding nominal amount) | SEK 10 million per bid |
| Expected allocation time | Not later than 10.15 (CET/CEST) on the Bid date |
| Delivery and payment date | 2025-10-21 |
| Settlement amount | To be paid to the Riksbank's account in Euroclear Sweden AB's securities settlement system SWIFT: VPCSSESSXXX Account: 1 4948 6383 CTM BIC: RIKSSESS ALERT acronym: RIKSBANK |
Stockholm, 2025-10-10
This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be retrieved at www.riksbank.se.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Brookfield Corporation10.10.2025 22:56:44 CEST | Press release
Brookfield Corporation to Host Third Quarter 2025 Results Conference Call
SKAKO A/S10.10.2025 22:34:56 CEST | Pressemeddelelse
Indkaldelse til ekstraordinær generalforsamling i SKAKO A/S
SKAKO A/S10.10.2025 22:28:59 CEST | Pressemeddelelse
SKAKO A/S indgår aftale om at sælge alle dets resterende driftsaktiviteter (SKAKO Vibration)
Teva Pharmaceutical Industries Ltd10.10.2025 21:00:22 CEST | Press release
FDA Approves Expanded Indication for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder
Bitfortune Group Ltd.10.10.2025 20:38:31 CEST | Press release
Rick Ross and gamma. partner with Bitfortune.com
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom